Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Use of enzymes in complex treatment of antiphospholipid syndrome in women with reproductive losses of andijan state

Gulnoza Maniyozova, Habiba Negmatshaeva, Ozoda Yuldasheva, Gulnoza Turaeva, Dilfura Parpieva

. 2014 ; 7 (2) : 1-2.

Jazyk angličtina Země Česko Médium elektronický zdroj

Typ dokumentu hodnotící studie

Perzistentní odkaz   https://www.medvik.cz/link/bmc15010747

Background: Obstetric complications developing at antiphospholipid syndrome are serious medical-social problem. Seeking of the treatment methods sets conditions for urgency of the article reviewed. Enzyme preparations are widely applied for treatment of women with fecundity disorder and hemorheology changes. Research objective was in clinico-laboratorial evaluation of Serrata drug impact in antiphospholipid syndrome in women with reproductive losses of Andijan state. Methods: Data of 43 women in the non-pregnancy state with reproductive losses (RL) in past history with revealed APS had been studied by us. Results: Thus, conducted therapy with Serrata was conductive to haemostasis. Conducted researches confirm the safety of application.

Use of enzymes in complex treatment of antiphospholipid syndrome in women with reproductive losses of andijan state [elektronický zdroj] /

Citace poskytuje Crossref.org

Bibliografie atd.

Literatura

000      
00000naa a2200000 a 4500
001      
bmc15010747
003      
CZ-PrNML
005      
20190528130107.0
007      
cr|cn|
008      
150322s2014 xr fs 000 0|eng||
009      
eAR
024    7_
$a 10.12955/emhpj.v7i2.502 $2 doi
040    __
$a ABA008 $d ABA008 $e AACR2 $b cze
041    0_
$a eng
044    __
$a xr
100    1_
$a Maniyozova, Gulnoza $u The Andijan State Medical Institute, Andijan, Uzbekistan
245    10
$a Use of enzymes in complex treatment of antiphospholipid syndrome in women with reproductive losses of andijan state $h [elektronický zdroj] / $c Gulnoza Maniyozova, Habiba Negmatshaeva, Ozoda Yuldasheva, Gulnoza Turaeva, Dilfura Parpieva
504    __
$a Literatura
520    9_
$a Background: Obstetric complications developing at antiphospholipid syndrome are serious medical-social problem. Seeking of the treatment methods sets conditions for urgency of the article reviewed. Enzyme preparations are widely applied for treatment of women with fecundity disorder and hemorheology changes. Research objective was in clinico-laboratorial evaluation of Serrata drug impact in antiphospholipid syndrome in women with reproductive losses of Andijan state. Methods: Data of 43 women in the non-pregnancy state with reproductive losses (RL) in past history with revealed APS had been studied by us. Results: Thus, conducted therapy with Serrata was conductive to haemostasis. Conducted researches confirm the safety of application.
650    12
$a antifosfolipidový syndrom $x etiologie $x farmakoterapie $x krev $7 D016736
650    _2
$a samovolný potrat $x prevence a kontrola $7 D000022
650    12
$a komplikace těhotenství $x prevence a kontrola $7 D011248
650    _2
$a fibrinolytika $x terapeutické užití $7 D005343
650    _2
$a antiflogistika $x terapeutické užití $7 D000893
650    12
$a enzymoterapie $x metody $x statistika a číselné údaje $7 D057487
650    _2
$a antioxidancia $x terapeutické užití $7 D000975
650    _2
$a hemostáza $x účinky léků $7 D006487
650    _2
$a kohortové studie $7 D015331
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a těhotenství $7 D011247
650    _2
$a výsledek terapie $7 D016896
653    00
$a Serrata
655    _2
$a hodnotící studie $7 D023362
700    1_
$a Negmatshaeva, Habiba $u The Andijan State Medical Institute, Andijan, Uzbekistan
700    1_
$a Yuldasheva, Ozoda $u The Andijan State Medical Institute, Andijan, Uzbekistan
700    1_
$a Turaeva, Gulnoza $u The Andijan State Medical Institute, Andijan, Uzbekistan
700    1_
$a Parpieva, Dilfura $u The Andijan State Medical Institute, Andijan, Uzbekistan
773    0_
$t European medical, health and pharmaceutical journal $x 1804-5804 $g Roč. 7, č. 2 (2014), s. 1-2 $w MED00177703
856    41
$u https://ojs.journals.cz/index.php/EMHPJ/issue/view/54 $y plný text volně přístupný
910    __
$a ABA008 $y 4 $z 0
990    __
$a 20150321103405 $b ABA008
991    __
$a 20190528130232 $b ABA008
999    __
$a ok $b bmc $g 1068198 $s 893585
BAS    __
$a 3 $a 4 $a PRD
BMC    __
$a 2014 $b 7 $c 2 $d 1-2 $i 1804-5804 $m European Medical, Health and Pharmaceutical Journal $n Eur. Med. Health Pharm. J. $x MED00177703
LZP    __
$c NLK121 $d 20151116 $a NLK 2015-16/vt

Najít záznam

Citační ukazatele

Možnosti archivace